Request for Covid-19 Impact Assessment of this Report
The United States Sphingosine-1-Receptor Modulators Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sphingosine-1-Receptor Modulators Drugs market, reaching US$ million by the year 2028. As for the Europe Sphingosine-1-Receptor Modulators Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sphingosine-1-Receptor Modulators Drugs players cover Novartis, Bristol-Myers Squibb, Johnson & Johnson, and Arena Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sphingosine-1-Receptor Modulators Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Fingolimod
Siponimod
Ozanimod
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia
Sun Pharma
Biocon
HEC Pharm Co. Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sphingosine-1-Receptor Modulators Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sphingosine-1-Receptor Modulators Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sphingosine-1-Receptor Modulators Drugs by Country/Region, 2017, 2022 & 2028
2.2 Sphingosine-1-Receptor Modulators Drugs Segment by Type
2.2.1 Fingolimod
2.2.2 Siponimod
2.2.3 Ozanimod
2.2.4 Other
2.3 Sphingosine-1-Receptor Modulators Drugs Sales by Type
2.3.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Type (2017-2022)
2.4 Sphingosine-1-Receptor Modulators Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Sphingosine-1-Receptor Modulators Drugs Sales by Application
2.5.1 Global Sphingosine-1-Receptor Modulators Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Application (2017-2022)
3 Global Sphingosine-1-Receptor Modulators Drugs by Company
3.1 Global Sphingosine-1-Receptor Modulators Drugs Breakdown Data by Company
3.1.1 Global Sphingosine-1-Receptor Modulators Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2020-2022)
3.2 Global Sphingosine-1-Receptor Modulators Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Company (2020-2022)
3.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Company
3.4 Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Product Location Distribution
3.4.2 Players Sphingosine-1-Receptor Modulators Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sphingosine-1-Receptor Modulators Drugs by Geographic Region
4.1 World Historic Sphingosine-1-Receptor Modulators Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Sphingosine-1-Receptor Modulators Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sphingosine-1-Receptor Modulators Drugs Annual Revenue by Geographic Region
4.2 World Historic Sphingosine-1-Receptor Modulators Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Sphingosine-1-Receptor Modulators Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Annual Revenue by Country/Region
4.3 Americas Sphingosine-1-Receptor Modulators Drugs Sales Growth
4.4 APAC Sphingosine-1-Receptor Modulators Drugs Sales Growth
4.5 Europe Sphingosine-1-Receptor Modulators Drugs Sales Growth
4.6 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Growth
5 Americas
5.1 Americas Sphingosine-1-Receptor Modulators Drugs Sales by Country
5.1.1 Americas Sphingosine-1-Receptor Modulators Drugs Sales by Country (2017-2022)
5.1.2 Americas Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2017-2022)
5.2 Americas Sphingosine-1-Receptor Modulators Drugs Sales by Type
5.3 Americas Sphingosine-1-Receptor Modulators Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sphingosine-1-Receptor Modulators Drugs Sales by Region
6.1.1 APAC Sphingosine-1-Receptor Modulators Drugs Sales by Region (2017-2022)
6.1.2 APAC Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2017-2022)
6.2 APAC Sphingosine-1-Receptor Modulators Drugs Sales by Type
6.3 APAC Sphingosine-1-Receptor Modulators Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sphingosine-1-Receptor Modulators Drugs by Country
7.1.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2017-2022)
7.1.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2017-2022)
7.2 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Type
7.3 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs by Country
8.1.1 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Type
8.3 Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sphingosine-1-Receptor Modulators Drugs
10.3 Manufacturing Process Analysis of Sphingosine-1-Receptor Modulators Drugs
10.4 Industry Chain Structure of Sphingosine-1-Receptor Modulators Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sphingosine-1-Receptor Modulators Drugs Distributors
11.3 Sphingosine-1-Receptor Modulators Drugs Customer
12 World Forecast Review for Sphingosine-1-Receptor Modulators Drugs by Geographic Region
12.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size Forecast by Region
12.1.1 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Region (2023-2028)
12.1.2 Global Sphingosine-1-Receptor Modulators Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Type
12.7 Global Sphingosine-1-Receptor Modulators Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Sphingosine-1-Receptor Modulators Drugs Product Offered
13.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Information
13.2.2 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Offered
13.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Main Business Overview
13.2.5 Bristol-Myers Squibb Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Offered
13.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Information
13.4.2 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Offered
13.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Arena Pharmaceuticals Main Business Overview
13.4.5 Arena Pharmaceuticals Latest Developments
13.5 Idorsia
13.5.1 Idorsia Company Information
13.5.2 Idorsia Sphingosine-1-Receptor Modulators Drugs Product Offered
13.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Idorsia Main Business Overview
13.5.5 Idorsia Latest Developments
13.6 Sun Pharma
13.6.1 Sun Pharma Company Information
13.6.2 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Offered
13.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sun Pharma Main Business Overview
13.6.5 Sun Pharma Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Sphingosine-1-Receptor Modulators Drugs Product Offered
13.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
13.8 HEC Pharm Co. Limited
13.8.1 HEC Pharm Co. Limited Company Information
13.8.2 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Offered
13.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 HEC Pharm Co. Limited Main Business Overview
13.8.5 HEC Pharm Co. Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Sphingosine-1-Receptor Modulators Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sphingosine-1-Receptor Modulators Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Fingolimod
Table 4. Major Players of Siponimod
Table 5. Major Players of Ozanimod
Table 6. Major Players of Other
Table 7. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2017-2022) & (K Units)
Table 13. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2017-2022)
Table 15. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Sphingosine-1-Receptor Modulators Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Sphingosine-1-Receptor Modulators Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Producing Area Distribution and Sales Area
Table 23. Players Sphingosine-1-Receptor Modulators Drugs Products Offered
Table 24. Sphingosine-1-Receptor Modulators Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Sphingosine-1-Receptor Modulators Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Sphingosine-1-Receptor Modulators Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Sphingosine-1-Receptor Modulators Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Sphingosine-1-Receptor Modulators Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Sphingosine-1-Receptor Modulators Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Americas Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Sphingosine-1-Receptor Modulators Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Sphingosine-1-Receptor Modulators Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Sphingosine-1-Receptor Modulators Drugs Sales by Application (2017-2022) & (K Units)
Table 50. APAC Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Application (2017-2022) & (K Units)
Table 58. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Sphingosine-1-Receptor Modulators Drugs
Table 68. Key Market Challenges & Risks of Sphingosine-1-Receptor Modulators Drugs
Table 69. Key Industry Trends of Sphingosine-1-Receptor Modulators Drugs
Table 70. Sphingosine-1-Receptor Modulators Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Sphingosine-1-Receptor Modulators Drugs Distributors List
Table 73. Sphingosine-1-Receptor Modulators Drugs Customer List
Table 74. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Forecast by Region
Table 76. Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Sphingosine-1-Receptor Modulators Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Sphingosine-1-Receptor Modulators Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novartis Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 96. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 101. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Bristol-Myers Squibb Main Business
Table 103. Bristol-Myers Squibb Latest Developments
Table 104. Johnson & Johnson Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 106. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Johnson & Johnson Main Business
Table 108. Johnson & Johnson Latest Developments
Table 109. Arena Pharmaceuticals Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 111. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Arena Pharmaceuticals Main Business
Table 113. Arena Pharmaceuticals Latest Developments
Table 114. Idorsia Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Idorsia Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 116. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Idorsia Main Business
Table 118. Idorsia Latest Developments
Table 119. Sun Pharma Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 121. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Sun Pharma Main Business
Table 123. Sun Pharma Latest Developments
Table 124. Biocon Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Biocon Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 126. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Biocon Main Business
Table 128. Biocon Latest Developments
Table 129. HEC Pharm Co. Limited Basic Information, Sphingosine-1-Receptor Modulators Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Offered
Table 131. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. HEC Pharm Co. Limited Main Business
Table 133. HEC Pharm Co. Limited Latest Developments
List of Figures
Figure 1. Picture of Sphingosine-1-Receptor Modulators Drugs
Figure 2. Sphingosine-1-Receptor Modulators Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sphingosine-1-Receptor Modulators Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sphingosine-1-Receptor Modulators Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Fingolimod
Figure 10. Product Picture of Siponimod
Figure 11. Product Picture of Ozanimod
Figure 12. Product Picture of Other
Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type in 2021
Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Sphingosine-1-Receptor Modulators Drugs Consumed in Hospital
Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Market: Hospital (2017-2022) & (K Units)
Figure 17. Sphingosine-1-Receptor Modulators Drugs Consumed in Clinic
Figure 18. Global Sphingosine-1-Receptor Modulators Drugs Market: Clinic (2017-2022) & (K Units)
Figure 19. Sphingosine-1-Receptor Modulators Drugs Consumed in Other
Figure 20. Global Sphingosine-1-Receptor Modulators Drugs Market: Other (2017-2022) & (K Units)
Figure 21. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application in 2021
Figure 23. Sphingosine-1-Receptor Modulators Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Company in 2021
Figure 25. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Sphingosine-1-Receptor Modulators Drugs Sales 2017-2022 (K Units)
Figure 30. Americas Sphingosine-1-Receptor Modulators Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Sphingosine-1-Receptor Modulators Drugs Sales 2017-2022 (K Units)
Figure 32. APAC Sphingosine-1-Receptor Modulators Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Sphingosine-1-Receptor Modulators Drugs Sales 2017-2022 (K Units)
Figure 34. Europe Sphingosine-1-Receptor Modulators Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country in 2021
Figure 38. Americas Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country in 2021
Figure 39. United States Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region in 2021
Figure 44. APAC Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Regions in 2021
Figure 45. China Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country in 2021
Figure 52. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Sphingosine-1-Receptor Modulators Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Sphingosine-1-Receptor Modulators Drugs in 2021
Figure 66. Manufacturing Process Analysis of Sphingosine-1-Receptor Modulators Drugs
Figure 67. Industry Chain Structure of Sphingosine-1-Receptor Modulators Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...